SCHEMBL5605875

SCHEMBL5605875

C=CCOC(=O)Oc1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
CYP3A4 P08684 2/20 0.43
TSHR P16473 3/20 0.42
GAA P10253 1/20 0.42
CACNA1D Q01668 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ELANE P08246 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
ABCB11 O95342 1/20 0.37
CYP1A2 P05177 1/20 0.37
HTR2A P28223 1/20 0.37
PMP22 Q01453 1/20 0.37
PPARA Q07869 1/20 0.37
LIPE Q05469 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10870487 0.91 CYP3A4 (0.50) KMT2AMEN1CYP3A4TSHRHPGD
SCHEMBL6152948 0.86 CYP3A4 (0.46) KMT2AMEN1CYP3A4TSHRGAA
SCHEMBL9717273 0.84 ALDH1A1 (0.48) CYP3A4TSHRGAAHPGDSMN1; SMN2
SCHEMBL10349842 0.83 CYP3A4 (0.41) KMT2AMEN1CYP3A4TSHRSMN1; SMN2
SCHEMBL6152601 0.83 ELANE (0.49) CYP3A4TSHRHPGDSMN1; SMN2ALDH1A1
SCHEMBL6151946 0.83 ELANE (0.46) KMT2AMEN1CYP3A4TSHRHPGD
SCHEMBL9174753 0.83 CYP3A4 (0.43) KMT2AMEN1CYP3A4TSHRSMN1; SMN2
SCHEMBL9700576 0.83 CYP3A4 (0.43) KMT2AMEN1CYP3A4TSHRGAA
SCHEMBL6153149 0.83 SNCA (0.51) KMT2AMEN1CYP3A4TSHRGAA
SCHEMBL1598844 0.83 LMNA (0.48) KMT2AMEN1CYP3A4TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7235698-B2 Enantioselective, catalytic allylation of ketones and olefins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2007-06-26 US claimed
US-20060084820-A1 Enantioselective, catalytic allylation of ketones and olefins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-04-20 US claimed
US-7235698-B2 Enantioselective, catalytic allylation of ketones and olefins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2007-06-26 US disclosed
US-20060084820-A1 Enantioselective, catalytic allylation of ketones and olefins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084820-A1 Enantioselective, catalytic allylation of ketones and olefins AKR1C2, TECR, AKR1C4 KMT2A 794/4885MEN1 3883/4885CYP3A4 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.